Persistence Therapeutics, Inc.
Chapel Hill, NC
- UEI
- P2Y3VBE9NFP8
- CAGE
- 153N9
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- Carolina Square Building C, 123 W Franklin St #550, Chapel Hill, NC 27516, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| The synthnode paradigm: reimagining car t cell therapy for improved patient outcomes - project summary car t cell… | National Cancer Institute | $629,370 |
Quick answers
What is Persistence Therapeutics, Inc.'s UEI?
Persistence Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is P2Y3VBE9NFP8.
What is Persistence Therapeutics, Inc.'s CAGE code?
Persistence Therapeutics, Inc.'s CAGE code is 153N9.
What is Persistence Therapeutics, Inc.'s primary NAICS code?
Persistence Therapeutics, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Persistence Therapeutics, Inc. located?
Persistence Therapeutics, Inc.'s physical address in SAM.gov is Carolina Square Building C, 123 W Franklin St #550, Chapel Hill, NC 27516, USA.
Is Persistence Therapeutics, Inc. registered in SAM.gov?
Yes. Persistence Therapeutics, Inc.'s SAM.gov registration is active through July 13, 2027.
What is Persistence Therapeutics, Inc.'s most recent federal award?
Persistence Therapeutics, Inc.'s most recent federal grant award is The synthnode paradigm: reimagining car t cell therapy for improved patient outcomes - project summary car t cell… (R44CA310319), from National Cancer Institute, on September 22, 2025.
On GovTribe
See Persistence Therapeutics, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors